The total number of human embryonic stem cell lines eligible for study with US federal fund is now 40, with the addition of 27 lines on Monday. According to The Scientist, NIH director Francis Collins, did, however, limit the use of these lines to diabetes-related pancreatic research, which was the consent forms stated the cells would be used to study. These lines were part of 28 submitted for approval by Harvard University.